News: News

Dexa Group took part in the Pledge Ceremony for Pharmaceutical Industry Maturity, held by Indonesia’s National Agency for Drug and Food Control (BPOM). In his opening remarks, BPOM’s Chief, Mr. Taruna Ikrar, emphasized the agency’s commitment to strengthening compliance within the pharmaceutical industry with existing regulations and standards. "Maturity is…

Dexa Group actively supports the enhancement of the quality and role of pharmacists in public health by participating in the 2024 Annual Scientific Meeting (PIT) of the Indonesian Pharmacists Association (IAI) held in Mataram, West Nusa Tenggara, on Thursday, August 29, 2024. The event was attended by the Head of…

PT Beta Pharmacon is actively contributing to sustainability efforts through its Environmental, Social, and Governance (ESG) program, implemented across its production processes. Two major initiatives have been implemented at PT Beta Pharmacon's site, which are the Solar Panel Program and the Conversion of Diesel Fuel to Natural Gas. "All of…

Dexa Group and other Natural Medicine (OBA) industries have received appreciation from the Indonesian Food and Drug Authority (BPOM) for becoming foster parents that provide education and training for the development of OBA for MSME manufacturers. This initiative is expected to strengthen the acceleration of pharmaceutical independence in Indonesia. The…

As a form of gratitude towards Dexa Group's 55-year journey and to demonstrate dedication to the health sector, Dexa Group, through Dharma Dexa, organized a cataract surgery social service for the community in Kupang. This social service was conducted in collaboration with RSUP dr. Ben Mboi on Tuesday, July 23,…

In alignment with the governmental health transformation initiative, PT Dexa Medica, through its Corporate Social Responsibility initiative, Dharma Dexa, invites people to partake in a chronic disease screening initiative named "Cek Segitiga." This campaign underscores the importance of health screenings. "PT Dexa Medica is spearheading the 'Cek Segitiga' initiative, facilitating…

PT Ferron Par Pharmaceuticals, in collaboration with the Indonesian Society of Endocrinology (PERKENI), held the Cardio-Vascular Metabolic (CVM) Summit titled "1st Ferron CVM Summit." During the event, Ferron launched its latest anti-diabetes product, Fliptin. The event was attended by Dexa Group CEO, Mr. Ferry Soetikno; Dexa Group President Commissioner, Mrs.…

Dexa Group has enhanced its corporate value of "Deal with Care" by donating an ambulance to the Army Health Education Center (Pusdikkes Puskesad) to improve healthcare services for the community around the Pusdikkes Puskesad Hospital. Mr. V Hery Sutanto, the leader of Dexa Medica, handed over the ambulance to Colonel…

Indonesia's potential wealth in natural resources, as the second-largest country in terms of biodiversity, boasting over 28 thousand species of plants and 2,848 medicinal plants, presents significant opportunities for the development of natural medicine and Indonesia Indigenous Modern Medicine (OMAI) phytopharmaceuticals. Dra. Reri Indriani, Senior Expert Pharmacist and Food Supervisor…

Dexa Group is a research-based pharmaceutical company committed to actively participating in developing phytopharmaca. This commitment aligns with the government's efforts to address the dependency on imported raw materials for medicines by utilizing the country's natural resources to produce phytopharmaca. "The government provides full support for developing medicines, including natural…